Cambridge Nutritional Sciences (CNSL) Competitors GBX 3.05 0.00 (0.00%) As of 12:02 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock CNSL vs. FOX, CEL, OTT, BCE, CZN, CHT, DVW, BRCI, NPT, and RCIShould you be buying Cambridge Nutritional Sciences stock or one of its competitors? The main competitors of Cambridge Nutritional Sciences include Fox Marble (FOX), Celadon Pharmaceuticals (CEL), Oxford Technology 3 Venture Capital Trust (OTT), Beacon Energy (BCE), Curzon Energy (CZN), 290005 (CHT.L) (CHT), 5008 (DVW.L) (DVW), BlackRock Comms Income Inv Tst (BRCI), NetPlay TV (NPT), and RapidCloud International (RCI). These companies are all part of the "communication" industry. Cambridge Nutritional Sciences vs. Fox Marble Celadon Pharmaceuticals Oxford Technology 3 Venture Capital Trust Beacon Energy Curzon Energy 290005 (CHT.L) 5008 (DVW.L) BlackRock Comms Income Inv Tst NetPlay TV RapidCloud International Fox Marble (LON:FOX) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, community ranking, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability. Does the media favor FOX or CNSL? In the previous week, Fox Marble's average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score. Company Overall Sentiment Fox Marble Neutral Cambridge Nutritional Sciences Neutral Does the MarketBeat Community favor FOX or CNSL? Fox Marble received 165 more outperform votes than Cambridge Nutritional Sciences when rated by MarketBeat users. CompanyUnderperformOutperformFox MarbleOutperform Votes16555.56% Underperform Votes13244.44% Cambridge Nutritional SciencesN/AN/A Which has more risk and volatility, FOX or CNSL? Fox Marble has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Comparatively, Cambridge Nutritional Sciences has a beta of 3.89, suggesting that its stock price is 289% more volatile than the S&P 500. Which has better earnings & valuation, FOX or CNSL? Fox Marble has higher earnings, but lower revenue than Cambridge Nutritional Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFox Marble£722.06K0.00-£2.04MN/AN/ACambridge Nutritional Sciences£9.77M0.74-£3.03MN/AN/A Is FOX or CNSL more profitable? Cambridge Nutritional Sciences has a net margin of -3.36% compared to Fox Marble's net margin of -282.21%. Cambridge Nutritional Sciences' return on equity of -3.34% beat Fox Marble's return on equity.Company Net Margins Return on Equity Return on Assets Fox Marble-282.21% -38.15% -10.32% Cambridge Nutritional Sciences -3.36%-3.34%-2.36% Do insiders & institutionals hold more shares of FOX or CNSL? 10.0% of Fox Marble shares are held by institutional investors. Comparatively, 10.2% of Cambridge Nutritional Sciences shares are held by institutional investors. 35.4% of Fox Marble shares are held by company insiders. Comparatively, 10.9% of Cambridge Nutritional Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryCambridge Nutritional Sciences beats Fox Marble on 6 of the 10 factors compared between the two stocks. Remove Ads Get Cambridge Nutritional Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNSL vs. The Competition Export to ExcelMetricCambridge Nutritional SciencesMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£7.26M£3.37B£5.54B£2.52BDividend YieldN/A1.99%5.35%4.90%P/E Ratio-362.1018.1223.25134.65Price / Sales0.74425.02361.26261,054.86Price / CashN/A146.5438.1627.90Price / Book0.762.626.494.45Net Income-£3.03M£99.80M£3.21B£5.77B7 Day Performance-2.24%-2.71%-6.42%-1.85%1 Month Performance-3.69%116.13%-0.68%-2.65%1 Year Performance-7.85%108.62%6.05%103.94% Cambridge Nutritional Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNSLCambridge Nutritional SciencesN/AGBX 3.05flatN/A-11.1%£7.26M£9.77M-362.103,200Gap UpFOXFox MarbleN/AN/AN/AN/A£5.63M£722,064.00-135.0010,600CELCeladon PharmaceuticalsN/AGBX 8-15.8%N/A-92.2%£4.91M£123,381.65-1.002,780Gap DownOTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M£-85,000.00-12.59203Gap DownBCEBeacon EnergyN/AGBX 0-25.0%N/A-93.8%£555,000.00N/A-0.3544,600Gap DownCZNCurzon EnergyN/AN/AN/AN/A£34,000.00N/A-3.4014,700Gap DownCHT290005 (CHT.L)N/AN/AN/AN/A£0.00N/A0.0020,300DVW5008 (DVW.L)N/AN/AN/AN/A£0.00N/A0.00N/AGap UpBRCIBlackRock Comms Income Inv TstN/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading VolumeNPTNetPlay TVN/AN/AN/AN/A£0.00N/A0.00147,000RCIRapidCloud InternationalN/AN/AN/AN/A£0.00N/A0.0023,000 Remove Ads Related Companies and Tools Related Companies Fox Marble Competitors Celadon Pharmaceuticals Competitors Oxford Technology 3 Venture Capital Trust Competitors Beacon Energy Competitors Curzon Energy Competitors 290005 (CHT.L) Competitors 5008 (DVW.L) Competitors BlackRock Comms Income Inv Tst Competitors NetPlay TV Competitors RapidCloud International Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CNSL) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
